does semaglutide cause liver damage Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss India has approved Wegovy (semaglutide

Interaction between fibroblasts and immune cells following DNA damage induced by ionizing radiation

Mounjaro may lead to greater average weight loss than Wegovy, but that does not mean it's better for everyone

[1] [3] Important safety considerations for long-term use include: Regular monitoring for gastrointestinal symptoms and appropriate management strategies Awareness of signs of pancreatitis (severe abdominal pain radiating to the back)

Fahey, Jed W., Xavier Haristoy, Patrick M

2018;8:e023830

The global GLP-1 analogues market size was calculated at USD 66.48 billion in 2025 and is predicted to increase from USD 88.58 billion in 2026 to approximately USD 1,062.90 billion by 2035, expanding at a CAGR of 31.94% from 2026 to 2035